PT - JOURNAL ARTICLE AU - Roman Bontsevich AU - Anna Adonina AU - Anastasiya Shershnieva AU - Yana Vovk AU - Galina Prozorova AU - Galina Batisheva AU - Andrey Kirichenko AU - Galina Ketova AU - Olga Kompaniets AU - Elena Luchinina AU - Vera Nevzorova TI - Comparison of physicians’ and medical students’ knowledge in the treatment and prevention of COPD according to the final results of the ASCO-II study AID - 10.1183/13993003.congress-2021.PA536 DP - 2021 Sep 05 TA - European Respiratory Journal PG - PA536 VI - 58 IP - suppl 65 4099 - http://erj.ersjournals.com/content/58/suppl_65/PA536.short 4100 - http://erj.ersjournals.com/content/58/suppl_65/PA536.full SO - Eur Respir J2021 Sep 05; 58 AB - Aim: to compare the doctors’ and medical students’ knowledge in the treatment and prevention of COPD.Materials and methods: an original questionnaire was developed in accordance to the GOLD-17 manual, 338 students and 421 physicians from 11 cities of Russia and Ukraine were surveyed in 2017-19. We analyzed 11 questions in this article.Results: The average level of correct answers (LCA) for the entire questionnaire was 40.6% among students, and it was significantly higher among physicians (52.1%, p<0.001).There were no significant difference (p >0.05) in LCA on such issues: delivery device with combination of drugs (67.8%phys - 59%stud), drugs of choice for treatment of moderate COPD exacerbation (47.4% - 40.7%).LCA among doctors was reliably better on such questions: role of anti-influenza vaccination (39.6% - 22.0%, p<0.001), respimate or nebulizer as an optimal delivery device for a patient with poor coordination and low respiratory rate (51.6% - 37.7%, p<0.001), initial therapy for COPD patients with advanced symptoms and a high risk of exacerbations (29.9% - 19.1%, p<0.01), and for low risk of exacerbations (55.6% - 38.2%, p<0.001), identification a clinical type of COPD with the given criteria (36.1% - 45.3%, p<0.05), drugs of choice for the empirical antibiotic treatment of infectious exacerbation (73.5% - 58.1%, p<0.001), reserve drugs in treating an infectious exacerbation (67.2% - 41.7%, p<0.001)Conclusions: We revealed a lack level of senior medical students’ and physicians’ knowledge in the prevention and treatment of COPD. Therefore it is necessary to introduce additional educational programs in this direction.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA536.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).